LAVAL, Quebec, Oct. 6, 2016 /CNW/ -- Valeant Pharmaceuticals
International, Inc. (NYSE: VRX and TSX: VRX) today announced that
Louis W. Yu, Ph.D. has been
appointed to the newly created position of Chief Quality Officer,
Global Quality, effective October 3,
2016.
Dr. Yu will report to Joseph C.
Papa, Chairman and CEO of Valeant. As a new member of
Valeant's Executive Committee, Dr. Yu will oversee all aspects of
quality and regulatory compliance for all of Valeant's global
businesses and operating sites.
Dr. Yu joins Valeant with more than 30 years of leadership
experience in the Quality and R&D functions of generic and
branded pharmaceutical companies. He was Executive Vice President,
Global Quality & Compliance at The Perrigo Company from
November 2006 to January 2016, where he was responsible for
strategic leadership and regulatory compliance as well as the
global patient safety/medical affairs departments. He also
served between May and September 2016
as the Senior Vice President, Global Quality and Compliance at
AMRI, a contract development and manufacturing organization (CDMO)
company.
"Delivering quality products leads to quality health outcomes,
and that is what we are focused on at Valeant," said Joseph C. Papa, chief executive officer of
Valeant. "Dr. Louis Yu is a great
addition to our organization, and we are delighted to bring him
into the company in the important new role of Chief Quality
Officer. Dr. Yu's deep quality leadership experience at a number of
branded and generic pharmaceutical companies gives him a deep
understanding of what our customers and regulators need, and I look
forward to working closely with him."
Dr. Yu said, "I appreciate the opportunity to lead Valeant's
global quality function and am eager to help the company implement
sustainable quality and compliance programs that will further
strengthen its businesses."
Biography of Louis W. Yu, Ph.
D.
Dr. Louis W. Yu is Chief
Quality Officer, Global Quality of Valeant Pharmaceuticals,
Inc.
Dr. Yu joined Valeant from AMRI where he was Senior Vice
President, Global Quality and Compliance. From November 2006 to January
2016, he served as Executive Vice President, Global Quality
and Compliance at The Perrigo Company, where he was responsible for
strategic leadership and regulatory compliance as well as the
global patient safety/medical affairs departments. Previously, he
served as the highest quality officer for CV Therapeutics, Forest
Laboratories and Solvay Pharmaceuticals USA. Earlier in his
career, he served in the Quality and R&D organizations for over
16 years at various Johnson & Johnson companies in positions of
increasing responsibility. He has been an adjunct professor at the
School of Pharmacy, the University of
Wisconsin, and currently is an adjunct faculty at the Purdue
Polytechnic Institute in West Lafayette. Dr. Yu earned a B.S. in
chemistry from the University of
Wisconsin, and a M.S. and Ph.D. in analytical chemistry from
Rutgers University.
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of dermatology,
gastrointestinal disorders, eye health, neurology and branded
generics. More information about Valeant can be found at
www.valeant.com.
Contact Information:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
Logo -
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-appoints-louis-w-yu-phd-as-chief-quality-officer-300340894.html
SOURCE Valeant Pharmaceuticals International, Inc.